Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. - Wikidata - wikimedia - TriplyDB

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

http://www.wikidata.org/entity/Q46337700

about

Toxicity of amphetamines: an update The clinical toxicology of metamfetamine Efficacy of psychostimulant drugs for amphetamine abuse or dependence Efficacy of Psychostimulant Drugs for Amphetamine Abuse or Dependence Pharmacotherapy for stimulant-related disorders The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys.The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans Effect of add-on valproate on craving in methamphetamine depended patients: A randomized trial Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.The Health Effect of Psychostimulants: A Literature Review Pharmacological approaches to methamphetamine dependence: a focused review.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.Extinction of drug cue reactivity in methamphetamine-dependent individuals.Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior.Bupropion attenuates methamphetamine self-administration in adult male rats.The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.The methamphetamine problem in the United States.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature Methamphetamine craving induced in an online virtual reality environment The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.Treatments for methamphetamine abuse: a literature review for the clinician.Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study Bupropion: pharmacology and therapeutic applications.Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.Bupropion improves attention but does not affect impulsive behavior in healthy young adults Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.The need for speed: an update on methamphetamine addiction.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse.Boundary conditions of methamphetamine craving Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys

P2860

Q22252794-1704F981-1FA4-4F65-814D-D5C27BF2A278 Q22305685-92F0FD8F-6FFB-4BBA-946A-8B99E94772C7 Q24198261-CC5E2A7B-72C0-4DD2-8324-BEC89838D0CA Q24203609-576D6164-6F45-4DE4-933E-F8F2BBDC248B Q26829186-05D78E34-3320-4F27-87F5-086E825695F8 Q27310644-0A832B56-6C62-4DD8-A1A0-AFC8D7A53A98 Q27310677-DC6CA1D2-71A8-41A5-89DE-A637135BAAC8 Q28240897-EA425847-938C-4AD8-8CB0-92CD5416113C Q28595633-0D0CC145-44D8-4628-82BE-3725390CDE42 Q30235058-750399A8-E646-437D-9FA2-BB95CD83E1B4 Q33449522-6C5301EC-61FC-4C04-80E6-B14562D98F2D Q33625390-0EBD9AB7-B695-4325-A296-C2639A687A95 Q33677986-7BB8AAFA-FD52-4DDC-AE24-EEF7274020F6 Q33906303-835E9192-4E85-458E-8943-164547869DAF Q34021980-575E8109-7263-490E-B4B3-E427EA4D8221 Q34036963-9DCB76A9-F134-494F-ABB8-DC46B6274D83 Q34044560-4EE1A6AE-C44C-4998-B127-61048A0F5D1D Q34044583-163AB975-29C4-4389-BEF5-D4FA2CD710FB Q34058096-A931F971-22CE-4C36-AB70-F49E5324BE84 Q34060576-34652D20-CCEC-478F-9F9D-A2790082038B Q34072874-7D2F9884-CC8E-42EF-BC61-C83685F021C4 Q34092520-DF0D1B09-D8A1-4B8F-9C6E-E85E621B5FB2 Q34181746-D23DDC2C-934A-4FA3-AE73-54CE11B286AA Q34182993-8CFA01DD-44A7-4C4D-8504-DE0FC721EC4D Q34223546-CD7A4804-94CA-45D8-A520-E7419B6B8697 Q34233794-059A3513-478D-4FFB-8714-41E24BC8EE7E Q34315501-F5D59E71-0B4A-404C-AB78-1FE7C6A911B5 Q34337044-576B3668-51BA-4E19-B41D-4204D7246D16 Q34569990-DD370AE6-FF7A-4822-99AE-F773086F0ADA Q34602596-16D7F701-2096-4E5E-81A1-E3705102ACEC Q34732652-2C628403-E42E-483F-8154-FB2DD47B6722 Q34756340-374A621D-C6FE-4538-8CB5-15A178BAC7DB Q34989747-2822AB9F-0CBF-4767-8944-49FC7F401E6F Q35012661-C8AEE12C-B91A-46CF-8986-511D3EBD5558 Q35576598-B53C11FF-A540-4010-8556-C8A55455D102 Q35580343-33460356-D175-4220-ACED-42987FA67439 Q35927318-79992CA2-C2D5-4D35-9240-B855683EE565 Q36315579-EB88FB66-5BA2-49E0-997C-CF74DD61C0AB Q36340654-8C00AA57-32FC-456A-B8F8-A81C2BA53A42 Q36494157-FCAC2A2E-47D1-4BE6-9B54-FB8A105020B5

P2860

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

http://www.wikidata.org/entity/Q46337700

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@en

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@nl

type

label

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@en

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@nl

prefLabel

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@en

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

@nl

P1433

Q46337700-F8589849-8AB8-40AD-A7DB-B2DE0A67744E

P1476

Q46337700-3B77E8B4-4D2A-4F97-9613-5EED5D10EE43

P2093

Q46337700-13F4A003-5D10-4D39-BFCC-54954E502535

Q46337700-15B98B17-F722-40FE-92BE-76F7FDCD9AB2

Q46337700-23E5CFAA-5028-4EFE-BFE6-E34C99F83F9E

Q46337700-553F6E9E-0B57-44FE-8106-AF3F5D1C09B2

Q46337700-BE5855BF-B8CA-4FF9-BEF7-0EE5F3268102

Q46337700-C729E8A5-E807-450C-8097-5740A55CECC5

Q46337700-F9091478-50CD-499D-9B5D-2F7DD1AD12D2

P2860

Q46337700-066D964B-39E6-421F-8762-B70495EA6C98

Q46337700-0D8AC393-46D5-41E1-85B9-69D0E12524F6

Q46337700-0E33622F-B37A-43F1-864F-A03B102A3B0C

Q46337700-1B9ABCE8-013C-43E8-AEF2-61B645568BC9

Q46337700-28A28401-A6A6-48B1-8A3F-1F9E20932B8C

Q46337700-2E5B4C52-8F4F-4049-84C2-68A17544737A

Q46337700-35FE6E4D-6D42-4A6C-B03D-548C28C99D4D

Q46337700-3F1C0455-152F-4F04-8354-CE96A61B9936

Q46337700-480082FC-BBA7-481B-93AC-7A71FC3EF005

Q46337700-4D70208E-BF7E-44BE-A262-E9DA81646CF5

P2888

Q46337700-1118A80D-B798-4E4D-BD88-44531487CE92

P304

Q46337700-A82623FE-6AAB-4DD3-9891-40696B3AA472

P31

Q46337700-E00D8211-51DA-405E-9790-695C31DD6A10

P356

Q46337700-0E94DCFE-7F6E-41F9-9B43-7E74024352DA

P407

Q46337700-C2FECFF0-CE43-4118-85A3-1840FFA8C8CF

P433

Q46337700-55A85825-AA5B-4EE7-84B4-6B5504ACA578

P478

Q46337700-FD84AA01-A509-4FD7-AE03-BC1ADCF4984B

P50

Q46337700-F45C1C41-5C49-48C5-B949-A28505F885DD

Q46337700-FE50C1E3-AA63-42F1-82F9-6289716E7901

P577

Q46337700-8515413E-7AEC-4A5F-9F71-72FA838D6623

P5875

Q46337700-A5A4D7B4-92FF-41E2-9619-124DF34EC689

P698

Q46337700-D809E790-6145-4388-A60F-AF8DA61FC728

P356

P1433

Neuropsychopharmacology

P1476

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving

@en

P2093

Ahmed Elkashef

http://www.w3.org/2001/XMLSchema#string

Christopher L Wallace

http://www.w3.org/2001/XMLSchema#string

John D Roache

http://www.w3.org/2001/XMLSchema#string

Nora Chiang

http://www.w3.org/2001/XMLSchema#string

Roberta Kahn

http://www.w3.org/2001/XMLSchema#string

Shou-Hua Li

http://www.w3.org/2001/XMLSchema#string

Timothy Fong

http://www.w3.org/2001/XMLSchema#string

P2860

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Pharmacological treatment of alcohol dependence: a review of the evidence.

Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.

Pharmacological treatment of cocaine dependence: a systematic review.

Review of bupropion for smoking cessation.

Novel approaches to the treatment of cocaine addiction.

Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.

P2888

P304

1537-1544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1300979

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Richard De La Garza

Thomas F Newton

P577

2005-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7448891

http://www.w3.org/2001/XMLSchema#string

P698

16319910

http://www.w3.org/2001/XMLSchema#string